What are brand‑name topical keratolytics (generic names in parentheses) for keratosis pilaris?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand-Name Topical Keratolytics for Keratosis Pilaris

For keratosis pilaris, the most commonly recommended brand-name keratolytic products are Eucerin Intensive Lotion (10% urea), AmLactin (12% lactic acid), and Balneum Plus (5% urea), with urea-based products being the most widely supported in clinical practice. 1

Primary Keratolytic Options

Urea-Based Products (First-Line)

  • Eucerin Intensive Lotion (10% urea) is the most frequently recommended brand-name product for keratosis pilaris, applied twice daily to affected areas 1
  • Higher concentration urea products (20% urea) are available for more severe cases, with one 4-week study demonstrating significant improvement in skin texture and patient satisfaction 2
  • Urea concentrations of at least 10% are required for effective keratolysis, with 20-40% concentrations reserved for severe localized hyperkeratosis 3, 1
  • Balneum Plus (5% urea) represents a lower-concentration option suitable for maintenance therapy 1

Alpha-Hydroxy Acid Products

  • AmLactin (12% lactic acid) is the most commonly used first-line therapy by dermatologists (43.63% of surveyed practitioners), followed by salicylic acid products (20.72%) 4
  • Lactic acid products at 10% concentration demonstrated 66% mean reduction in lesions over 12 weeks in comparative studies 5
  • Glycolic acid products are also preferred topicals for keratosis pilaris management, though specific brand names are less consistently cited 6

Salicylic Acid Products

  • 5% salicylic acid creams showed 52% mean reduction in lesions over 12 weeks, though slightly less effective than lactic acid 5
  • Salicylic acid is the second most utilized first-line therapy among dermatologists 4

Application Guidelines

Standard Regimen

  • Apply keratolytic products twice daily to affected areas, ideally after bathing when skin is slightly damp to optimize absorption 1
  • For severe cases, 10% urea cream can be applied three times daily 1
  • Treatment typically requires 4-12 weeks to achieve significant improvement 5, 2

Critical Safety Considerations

  • Avoid using urea ≥10% in children under 1 year of age, except once daily on limited areas like palms and soles, due to immature epidermal barrier and risk of systemic absorption 3, 1
  • Do not apply to the face, flexures, inflamed skin, or open fissures, as keratolytics may cause irritation, burning, or stinging 1
  • Common side effects include mild irritation, itching, and burning sensation at application sites 1

Clinical Pearls

Treatment Expectations

  • Over 60% of patients experience recurrence within 3 months of stopping salicylic acid or moisturizer treatment, indicating the need for long-term maintenance therapy 4
  • Urea products demonstrate superior efficacy compared to plain emollients, with vehicle-controlled trials showing only 44% clearance with simple emollients versus significantly higher rates with keratolytic formulations 1

Combination Approach

  • Keratolytics can be used as monotherapy or combined with topical corticosteroids for inflammatory components 1
  • Urea enhances penetration of other topical medications, making it useful in combination regimens 1

References

Guideline

Urea-Containing Emollients for Dry Skin and Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris.

Journal of drugs in dermatology : JDD, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Keratosis Pilaris: Treatment Practices of Board-Certified Dermatologists.

Journal of drugs in dermatology : JDD, 2023

Research

Epidermal permeability barrier in the treatment of keratosis pilaris.

Dermatology research and practice, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.